Simplify Life with Omnipod® 5!
Why Omnipod 5?
- The first and only tubeless, waterproof† hybrid closed loop system compatible with leading sensor brands
- Automatically adjusts insulin every five minutes¹,²
- Delivered more than 80% time in range with optimised settings3.
Already a Podder®? Find everything you need in one place, in your personal user portal.
What is Omnipod®?
Omnipod is a range of tubeless insulin delivery systems designed for people living with type 1 diabetes.
Each waterproof†, wearable Pod continuously delivers personalised doses of insulin for up to three days (72 hours).
With no tubes to cause unwanted tangles, it’s time to discover the freedom of Omnipod.
Meet our Omnipod® lineup
Omnipod 5 Automated Insulin Delivery System
Experience the freedom of automated insulin delivery and improved time in range1,2 with compatibility across leading sensor brands.
Omnipod DASH® Insulin Management System
You’re in control with the Omnipod DASH® Personal Diabetes Manager. Discover discreet, precise insulin dosing and customisable programmes designed to fit around your lifestyle.
We believe in freedom of choice
At Insulet, we believe those who have been deemed eligible for pump therapy should have the freedom to choose and the flexibility to change insulin delivery devices with no ‘lock-in’ periods, we call this the OmnipodPromise®.
Are you new to pump therapy, or considering switching to a different insulin pump? Find out more about how our commitment to choice may help you. Find out more about OmnipodPromise®.
Here’s what our Podders have to say about Omnipod…
When I first put Omnipod on, I felt free. There were no wires coming off me.
Lochlan
Podder® since 2023
Omnipod has helped me gain confidence in so many areas of my life, it makes me feel like I have something in my corner helping me everyday.
Temi
Podder® since 2021
Omnipod 5 was a game-changer for me. It empowered me and gave me back so much of my independence.
Sophie
Podder® since 2023
Ready to try?
Curious what life could feel like with more freedom and fewer daily interruptions?
Whether you want a hands-on trial* or a live demo, we’re here to help you get started with confidence.
* [Requires compatible sensors. Bolus for meals and corrections are still needed.]
† The Pod has an IP28 rating for up to 7.6 metres (25 feet) for 60 minutes. The Omnipod 5 Controller is not waterproof. Please see sensor manufacturer user guide for sensor waterproof rating ‡ Finger pricks required for diabetes treatment decisions if symptoms or expectations do not match readings.
1. Brown S. et al. Diabetes Care. 2021;44:1630-1640. Prospective pivotal trial in 240 participants with T1D aged 6 - 70 yrs. Study included a 14-day standard therapy (ST) phase followed by a 3-month Omnipod 5 hybrid closed-loop (HCL) phase. Mean time in range (3.9-10.0 mmol/L or 70-180mg/dL) in adults/adolescents as measured by CGM: ST = 64.7%, 3-mo Omnipod 5 = 73.9%, P<0.0001. Mean time in range (3.9-10.0 mmol/L or 70-180mg/dL) in children as measured by CGM: ST = 52.5%, 3-mo Omnipod 5 = 68.0%, P<0.0001.
2. Sherr J. et al. Diabetes Care. 2022; 45:1907-1910. Single-arm multicenter clinical trial in 80 pre-school children (aged 2-5.9 yrs) with T1D. Study included a 14-daystandard therapy (ST) phase followed by a 3-month AID phase with Omnipod 5 system.. Mean time in range (3.9-10.0 mmol/L or 70-180mg/dL) as measured by CGM in children ST vs. 3-mo Omnipod 5: 57.2% vs 68.1%, P<0.0001.
3. Retrospective RWE data on file. 2025. Results shown for users with optimized settings including sufficient CGM data (≥75% of days with ≥220 readings), ≥90% time in Automated Mode, ≥5 bolus/day and an average Target Glucose of 110-115 mg/dL (6.1-6.4 mmol/L). Optimized settings: ISF x TDI ≤1500 (83 mmol/L), I:C Ratio x TDI ≤350. RF-062025-00014.